244 related articles for article (PubMed ID: 23526995)
1. Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias.
Kierdorf K; Katzmarski N; Haas CA; Prinz M
PLoS One; 2013; 8(3):e58544. PubMed ID: 23526995
[TBL] [Abstract][Full Text] [Related]
2. Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.
Peake K; Manning J; Lewis CA; Barr C; Rossi F; Krieger C
J Vis Exp; 2015 Apr; (98):e52553. PubMed ID: 25867947
[TBL] [Abstract][Full Text] [Related]
3. Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.
Youshani AS; Rowlston S; O'Leary C; Forte G; Parker H; Liao A; Telfer B; Williams K; Kamaly-Asl ID; Bigger BW
J Neuroinflammation; 2019 Feb; 16(1):25. PubMed ID: 30722781
[TBL] [Abstract][Full Text] [Related]
4. Effects of myeloablation, peripheral chimerism, and whole-body irradiation on the entry of bone marrow-derived cells into the brain.
Lampron A; Lessard M; Rivest S
Cell Transplant; 2012; 21(6):1149-59. PubMed ID: 21944997
[TBL] [Abstract][Full Text] [Related]
5. Targeting myeloid cells to the brain using non-myeloablative conditioning.
Böttcher C; Fernández-Klett F; Gladow N; Rolfes S; Priller J
PLoS One; 2013; 8(11):e80260. PubMed ID: 24244666
[TBL] [Abstract][Full Text] [Related]
6. Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation.
Yang Y; Jorstad NL; Shiao C; Cherne MK; Khademi SB; Montine KS; Montine TJ; Keene CD
Exp Mol Pathol; 2013 Aug; 95(1):7-17. PubMed ID: 23567123
[TBL] [Abstract][Full Text] [Related]
7. Myelosuppressive conditioning using busulfan enables bone marrow cell accumulation in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
Lewis CA; Manning J; Barr C; Peake K; Humphries RK; Rossi F; Krieger C
PLoS One; 2013; 8(4):e60661. PubMed ID: 23593276
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
9. Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness.
Inverardi L; Linetsky E; Pileggi A; Molano RD; Serafini A; Paganelli G; Ricordi C
Transplantation; 2004 Mar; 77(5):647-55. PubMed ID: 15021823
[TBL] [Abstract][Full Text] [Related]
10. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
[TBL] [Abstract][Full Text] [Related]
11. Submyeloablative conditioning with busulfan permits bone marrow-derived cell accumulation in a murine model of Alzheimer's disease.
Barr CM; Manning J; Lewis CA; Rossi FM; Krieger C
Neurosci Lett; 2015 Feb; 588():196-201. PubMed ID: 25582787
[TBL] [Abstract][Full Text] [Related]
12. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
[TBL] [Abstract][Full Text] [Related]
13. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation.
Ashizuka S; Peranteau WH; Hayashi S; Flake AW
Exp Hematol; 2006 Mar; 34(3):359-68. PubMed ID: 16543070
[TBL] [Abstract][Full Text] [Related]
14. Low dose busulfan facilitates chimerism and tolerance in a murine model.
Anam K; Black AT; Hale DA
Transpl Immunol; 2006 Jan; 15(3):199-204. PubMed ID: 16431286
[TBL] [Abstract][Full Text] [Related]
15. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
17. Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers.
van Pel M; van Breugel DW; Vos W; Ploemacher RE; Boog CJ
Bone Marrow Transplant; 2003 Jul; 32(1):15-22. PubMed ID: 12815473
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts.
Lapidot T; Terenzi A; Singer TS; Salomon O; Reisner Y
Blood; 1989 May; 73(7):2025-32. PubMed ID: 2653469
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice.
Yeager AM; Shinn C; Pardoll DM
Blood; 1991 Dec; 78(12):3312-6. PubMed ID: 1683798
[TBL] [Abstract][Full Text] [Related]
20. Use of Busulfan to Condition Mice for Bone Marrow Transplantation.
Montecino-Rodriguez E; Dorshkind K
STAR Protoc; 2020 Dec; 1(3):100159. PubMed ID: 33377053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
